Who owns CYTOKINETICS INC?
- CUSIP Number: 23282wac4
Tip: Access positions for across all investors
Analyze quarterly positions in Cytokinetics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cytokinetics stock
Who bought or sold CYTOKINETICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Wolverine Asset Management | 82M | $131M | -14% | Mar 2024 |
|
| Citadel Advisors | 44M | $70M | 1009% | Mar 2024 |
|
| Balyasny Asset Management | 39M | $61M | 83% | Mar 2024 |
|
| D. E. Shaw & Co | 23M | $36M | -22% | Mar 2024 |
|
| Polygon Management | 20M | $32M | 76% | Mar 2024 |
|
| FMR | 19M | $30M | 100% | Mar 2024 |
|
| Sona Asset Management | 19M | $30M | 100% | Mar 2024 |
|
| DeepCurrents Investment Group | 17M | $28M | -13% | Mar 2024 |
|
| Millennium Management | 15M | $24M | -26% | Mar 2024 |
|
| Point72 Asset Management | 15M | $24M | -12% | Mar 2024 |
|
| Partner Fund Management | 8.0M | $14M | -68% | Dec 2023 |
|
| Flow State Investments | 7.5M | $12M | 100% | Mar 2024 |
|
| Ameriprise Financial | 6.5M | $10M | -72% | Mar 2024 |
|
| Morgan Stanley | 6.2M | $9.8M | -28% | Mar 2024 |
|
| Verition Fund Management | 5.6M | $8.8M | 85623% | Mar 2024 |
|
| Jane Street | 5.4M | $8.6M | -49% | Mar 2024 |
|
| Sunrise Partners Limited Partnership | 5.4M | $8.6M | 100% | Mar 2024 |
|
| SSI Investment Management | 4.9M | $8.6M | 38% | Dec 2023 |
|
| Capstone Investment Advisors | 4.7M | $7.5M | 0% | Mar 2024 |
|
| BlackRock | 4.5M | $7.1M | -79% | Mar 2024 |
|
| Nicholas Investments Partners | 3.0M | $5.3M | 20% | Dec 2023 |
|
| Franklin Resources | 2.6M | $4.2M | 100% | Mar 2024 |
|
| Warberg Asset Management | 2.3M | $3.7M | 100% | Mar 2024 |
|
| Wellington Management Company | 2.2M | $3.8M | 0% | Dec 2023 |
|
| Bank of America Corporation | 2.1M | $3.3M | 1093% | Mar 2024 |
|
| Lord, Abbett & Co | 1.6M | $2.5M | -78% | Mar 2024 |
|
| Bnp Paribas Investment Partners | 1.5M | $2.4M | 100% | Mar 2024 |
|
| Aequim Alternative Investments | 1.5M | $2.4M | 0% | Mar 2024 |
|
| Credit Suisse | 1.2M | $1.1M | -25% | Mar 2024 |
|
| Lazard Asset Management | 500k | $880k | -83% | Dec 2023 |
|
| Wells Fargo & Company | 380k | $603k | 100% | Mar 2024 |
|
| Central Pacific Bank - Trust Division | 202k | $331k | 100% | Mar 2024 |
|
| Bank of New York Mellon | 200k | $317k | -50% | Mar 2024 |
|
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 200k | $317k | -87% | Mar 2024 |
|
| Barclays | 176k | $279k | -85% | Mar 2024 |
|
| Calamos Advisors | 136k | $216k | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 98k | $156k | 15% | Mar 2024 |
|
| Edmond De Rothschild Holding | 80k | $127k | -93% | Mar 2024 |
|
| First Hawaiian Bank | 78k | $124k | -21% | Mar 2024 |
|
| SG Americas Securities | 20k | $3.2M | -11% | Mar 2024 |
|
| Boussard & Gavaudan Investment Management | 6.4k | $10M | 100% | Mar 2024 |
|
| Nomura Holdings | 5.7k | $403k | 0% | Mar 2024 |
|
| Natixis | 399.00 | $640k | -94% | Mar 2024 |
|
Who sold out of Cytokinetics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Weiss Asset Management LP[1 | Dec 2023 | 47M | $82M |
| Graham Capital Management | Dec 2023 | 17M | $30M |
| Readystate Asset Management | Dec 2023 | 15M | $27M |
| Linden Advisors | Sep 2023 | 12M | $9.8B |
| CNH Partners | Dec 2023 | 11M | $20M |
| Polar Securities | Dec 2023 | 7.5M | $13M |
| CSS | Dec 2023 | 6.4M | $11M |
| Citigroup | Dec 2023 | 3.1M | $5.5M |
| Man Group | Dec 2023 | 2.6M | $4.5M |
| Royal Bank of Canada | Dec 2023 | 2.2M | $3.9M |
| Shenkman Capital Management | Dec 2023 | 1.7M | $3.0B |
| Goldman Sachs Group | Dec 2023 | 938k | $1.6M |
| Boothbay Fund Management | Sep 2023 | 360k | $307k |
| Leucadia National Corporation | Dec 2023 | 300k | $528k |
| KBC Group NV | Sep 2023 | 100k | $86k |
| Stonegate Investment Group | Dec 2023 | 11k | $19k |